Invariant natural killer T cells in chronic obstructive pulmonary disease

Respirology

Volumn 17, Issue 3, 2012, Pages 486-492

  Chi, Su Young ^a   Ban, Hee Jung ^a   Kwon, Yong Soo ^a   Oh, In Jae ^a   Kim, Kyu Sik ^a   Kim, Yu Il ^a   Kim, Young Chul ^a   Lim, Sung Chul ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

chronic obstructive pulmonary disease; invariant natural killer T cell; pathogenesis; pulmonary function

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1 ANTIGEN; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD CELL; BLOOD STAIN; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; NATURAL KILLER T CELL; PRIORITY JOURNAL;

AGED; ANTIGENS, CD1; CD4 LYMPHOCYTE COUNT; FEMALE; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; HUMANS; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS;

EID: 84859033550     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.02104.x     Document Type: Article

References (31)

1. Saetta M, Di Stefano A, Turato G, et al,. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157: 822-6.
2. Finkelstein R, Fraser RS, Ghezzo H, et al,. Alveolar inflammation and its relation to emphysema in smokers. Am. J. Respir. Crit. Care Med. 1995; 152: 1666-72.
3. Finkelstein R, Ma HD, Ghezzo H, et al,. Morphometry of small airways in smokers and its relationship to emphysema type and hyperresponsiveness. Am. J. Respir. Crit. Care Med. 1995; 152: 267-76.
4. Fairclough L, Urbanowicz RA, Corne J, et al,. Killer cells in chronic obstructive pulmonary disease. Clin. Sci. (Lond.) 2008; 114: 533-41.
5. Hogg JC, Chu F, Utokaparch S, et al,. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004; 350: 2645-53.
6. Retamales I, Elliott WM, Meshi B, et al,. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am. J. Respir. Crit. Care Med. 2001; 164: 469-73.
7. O'Shaughnessy TC, Ansari TW, Barnes NC, et al,. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am. J. Respir. Crit. Care Med. 1997; 155: 852-7.
8. Majo J, Ghezzo H, Cosio MG,. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. Eur. Respir. J. 2001; 17: 946-53.
9. Saetta M, Baraldo S, Corbino L, et al,. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 160: 711-17.
10. Di Stefano A, Caramori G, Capelli A, et al,. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur. Respir. J. 2004; 24: 78-85.
11. Kronenberg M, Gapin L,. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2002; 2: 557-68.
12. Emoto M, Kaufmann SH,. Liver NKT cells: an account of heterogeneity. Trends Immunol. 2003; 24: 364-9.
13. Norris S, Doherty DG, Collins C, et al,. Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Valpha24-JalphaQ and gammadelta T cell receptor bearing cells. Hum. Immunol. 1999; 60: 20-31.
14. Kenna T, Golden-Mason L, Porcelli SA, et al,. NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells. J. Immunol. 2003; 171: 1775-9.
15. Taniguchi M, Harada M, Kojo S, et al,. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 2003; 21: 483-513.
16. Akbari O, Stock P, Meyer E, et al,. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 2003; 9: 582-8.
17. Lisbonne M, Diem S, Keller A, et al,. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 2003; 171: 1637-41.
18. Koh YI, Shim JU, Wi JO, et al,. Inverse association of peripheral blood CD4(+) invariant natural killer T cells with atopy in human asthma. Hum. Immunol. 2010; 71: 186-91.
19. Akbari O, Faul JL, Hoyte EG, et al,. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 2006; 354: 1117-29.
20. Vijayanand P, Seumois G, Pickard C, et al,. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N. Engl. J. Med. 2007; 356: 1410-22.
21. Rabe KF, Hurd S, Anzueto A, et al,. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176: 532-55.
22. Anthonisen NR, Manfreda J, Warren CP, et al,. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann. Intern. Med. 1987; 106: 196-204.
23. Dellabona P, Padovan E, Casorati G, et al,. An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J. Exp. Med. 1994; 180: 1171-6.
24. Boyson JE, Rybalov B, Koopman LA, et al,. CD1d and invariant NKT cells at the human maternal-fetal interface. Proc. Natl Acad. Sci. U. S. A. 2002; 99: 13741-6.
25. Godfrey DI, MacDonald HR, Kronenberg M, et al,. NKT cells: what's in a name? Nat. Rev. Immunol. 2004; 4: 231-7.
26. Gumperz JE, Miyake S, Yamamura T, et al,. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 2002; 195: 625-36.
27. Hamzaoui A, Cheik Rouhou S, Grairi H, et al,. NKT cells in the induced sputum of severe asthmatics. Mediators Inflamm. 2006; 2006: 71214.
28. Bessoles S, Dudal S, Besra FS, et al,. Human CD4+ invariant NKT cells are involved in antibacterial immunity against Brucella suis through CD1d-dependent but CD4-independent mechanisms. Eur. J. Immunol. 2009; 39: 1025-35.
29. Biron CA, Brossay L,. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 2001; 13: 458-64.
30. Ikegami Y, Yokoyama A, Haruta Y, et al,. Circulating natural killer T cells in patients with asthma. J. Asthma 2004; 41: 877-82.
31. Makris D, Lazarou S, Alexandrakis M, et al,. Tc2 response at the onset of COPD exacerbations. Chest 2008; 134: 483-8.